Behind High Blood Pressure and Anxiety, a Hidden Diagnosis: The Overlooked Rise of Adrenal Disorders

April marks Adrenal Awareness Month, a national initiative focused on a group of hormonal disorders that are frequently overlooked, often misdiagnosed, and in some cases life-threatening if left untreated. Many adrenal disorders present with symptoms that mimic common conditions—such as high blood pressure, anxiety, weight gain, or fatigue—leading patients to go undiagnosed for years.

Adrenal Awareness Month expands its focus to spotlight a broader range of adrenal disorders, including Cushing’s syndromepheochromocytomaConn’s syndrome, and adrenal cancer. Each condition will be featured throughout the month, offering targeted education, resources, and increased visibility for these complex and often overlooked diseases.

Cushing’s syndrome results from prolonged exposure to elevated cortisol levels, often caused by adrenal or pituitary tumors. Symptoms can include rapid weight gain, particularly in the face and abdomen, thinning skin, muscle weakness, and high blood pressure—features that frequently overlap with more common conditions, delaying diagnosis. Pheochromocytoma is a rare but potentially life-threatening tumor of the adrenal glands that causes excessive release of catecholamines, including adrenaline. This can lead to sudden episodes of severe high blood pressure, headaches, rapid heart rate, sweating, and anxiety or panic-like symptoms. Because these episodes can occur unpredictably, diagnosis is often challenging. When properly identified, however, pheochromocytoma is highly treatable, particularly with specialized surgical care. Conn’s syndrome (primary hyperaldosteronism) is a leading but often unrecognized cause of secondary hypertension. Studies suggest that up to 10% of patients with high blood pressure may have an underlying hormonal cause such as Conn’s syndrome—yet many remain undiagnosed. The condition occurs when an adrenal tumor produces excess aldosterone, causing the body to retain sodium and lose potassium. This imbalance can lead to persistent high blood pressure, fatigue, muscle weakness, and increased cardiovascular risk. Because these symptoms often overlap with more common conditions, Conn’s syndrome is frequently overlooked or misdiagnosed.

“Adrenal disorders often present with symptoms that overlap with more common conditions, which is why they can go unrecognized for years,” said Tobias Carling, MD, PhD, FACS. “The challenge is that these are not just complex conditions—they can be serious and even life-threatening if missed. The good news is that many are highly treatable, and in some cases curable, when diagnosed early.” Early diagnosis and expert surgical treatment can be life-changing—and in many cases, curative.

Dr. Carling and his team operate at the Hospital for Endocrine Surgery, home to the highest-volume endocrine surgery program in the world.Adrenal conditions are frequently overlooked, leaving patients to manage symptoms such as hypertension, fatigue, anxiety, or metabolic changes without identifying the underlying cause. Increasing awareness and encouraging appropriate screening are critical steps toward improving diagnosis and treatment outcomes.

Individuals experiencing persistent high blood pressure, unexplained weight changes, episodic anxiety, or abnormal potassium levels are encouraged to speak with their physician about further evaluation. Direct-to-consumer testing options, including specialized adrenal panels, are also available through providers such as Any Lab Test Now.

To further elevate awareness and bring a human perspective to these conditions, former patients of the Hospital for Endocrine Surgery are invited to share their personal stories. By visiting:
https://hospital-for-endocrine-surgery.boast.io/form/conns-awareness-day
patients can contribute their experiences—helping others better understand symptoms, treatment journeys, and life-changing outcomes associated with adrenal disorders.

“It is our hope to amplify the voices of those who have experienced these conditions firsthand,” Dr. Carling added. “By sharing these stories, we can help others recognize symptoms earlier, seek appropriate care, and ultimately improve outcomes for patients worldwide.”

Throughout April, patients, providers, and advocates are encouraged to participate, share information, and help bring long-overdue visibility to adrenal health.

About the Carling Adrenal Center
Founded by Dr. Tobias Carling, a global leader in adrenal gland surgery, the Carling Adrenal Center is an international destination for the surgical treatment of adrenal tumors. After nearly 20 years at Yale University—including seven years as Chief of Endocrine Surgery—Dr. Carling founded the center in 2020. Today, it performs more adrenal operations than any other hospital in the world. Learn more at www.adrenal.com or call (813) 972-0000.

About Hospital for Endocrine Surgery
The Hospital for Endocrine Surgery, a campus of HCA Florida South Tampa Hospital, specializes in the diagnosis and surgical treatment of thyroid, parathyroid, and adrenal tumors. The hospital is dedicated to compassionate, patient-centered care and is recognized as the nation’s highest-volume center for endocrine tumor treatment. Learn more at www.hospitalforendocrinesurgery.com.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media

From https://www.registerguard.com/press-release/story/51335/behind-high-blood-pressure-and-anxiety-a-hidden-diagnosis-the-overlooked-rise-of-adrenal-disorders/

Helpful Doctors: Dr. Ricardo Correa

Ricardo Correa, MD, MEd, has been recognized as a 2023 Castle Connolly Top Doctor — the first time he has received the prestigious Top Doctor honor.

CLEVELAND, OH, October 19, 2023 /24-7PressRelease/ — Ricardo Correa, MD, MEd, has been recognized as a 2023 Castle Connolly Top Doctor — the first time he has received the prestigious Top Doctor honor. Only about 7 percent of the nation’s licensed physicians are selected annually as Castle Connolly Top Doctors in their regions for their specialties.

Dr. Correa is an endocrinologist, Endocrinology Fellowship program director, and Health Equity and Inclusive director with the Cleveland Clinic Endocrinology & Metabolism Institute.

He has special expertise in transgender medicine; neuroendocrinology; and caring for adults with adrenal disorders, such as Cushing’s syndrome, Addison’s disease, primary hyperaldosteronism, neuroendocrine tumors, and rare endocrine conditions.

Dr. Correa is certified by the American Board of Internal Medicine, with subspecialty certification in endocrinology, diabetes, and metabolism as well as nutrition. In addition, he is board certified in medical quality.

Dr. Correa is a Fellow of the American College of Physicians, the American Association of Clinical Endocrinology, the Academy for Physicians in Clinical Research, and the American College of Medical Quality.

In addition to his clinical activities, Dr. Correa serves as a clinical professor of medicine, director for longitudinal didactics, and director for mentoring and belonging — among many other roles — for the Lerner College of Medicine and the School of Medicine at Case Western Reserve University. He’s also a volunteer researcher at the Phoenix VA Medical Center and director of the Health Equity Fellowship at Creighton School of Medicine in Phoenix.

He leads Cleveland Clinic’s Endocrine Health Equity Initiatives and focuses on decreasing disparities among underrepresented minorities with diabetes, obesity, and rare endocrine conditions and health care.

Dr. Correa is a major and battalion surgeon with the U.S. Army Physician Reserve, 492nd CA Battalion.

Dr. Correa is involved in many local and national organizations and efforts related to caring for underserved communities and gender-diverse communities and promoting diversity, equity, and inclusion and volunteerism.

He speaks Spanish and English.

Dr. Correa earned his medical degree at the Universidad De Panama Faculty of Medicine in Panama City. He completed a three-year internal medicine residency at Miami’s Jackson Memorial Hospital, followed by a three-year fellowship in endocrinology, metabolism, and diabetes at the National Institutes of Health, where he focused on neuroendocrine disorders. He further trained with a one-year nutrition fellowship. He has completed multiple leadership fellowships including the Presidential Leadership Scholar Fellowship, NHMA Leadership Fellowship, and Climate Change and Health Equity Fellowship, among others.

He also holds a master’s degree (EdD) in education from the Universidad De Panama. He has published more than 100 articles in highly quality peer-reviewed journals and he is very involved in research with several grants and awards that he has earned.

Dr. Correa maintains active profiles on InstagramFacebookX (Twitter), and LinkedIn – offering valuable insights and updates to his professional network.

Top Doctors are nominated by peer physicians and selected by the physician-led Castle Connolly research team.

About Castle Connolly
Castle Connolly publishes its Top Doctors list at castleconnolly.com and in a variety of print and online partner publications. Nominations are open to all board-certified MDs, DOs, and DPMs. The Castle Connolly team chooses honorees based on nominee criteria that includes their medical education, training, hospital appointments, and disciplinary histories.

Doctors do not and cannot pay to be selected as a Castle Connolly Top Doctor.